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ABSTRACT The kinetics of inhibition of 5'-adenylic acid deaminase and creatine-
ATP transphosphorylase by their respective antibodies are studied and rate
constants of combination are ascertained. It is shown that the single substrate
5'-adenylic acid (AMP) of deaminase "protects" the enzyme against antibody
inhibition. However, phosphate, a competitive inhibitor of the highly specific
deaminase, enhances combination with antibody. With creatine kinase, however,
addition of either of the substrates, alone or in combination with the required
magnesium, each of which separately bind to the enzyme, does not prevent in-
hibition of the enzyme by its antibody. However, the "working" enzyme com-
bined with all substrates is "protected" against antibody inhibition.
Earlier work on the "trophic" influence of the central nervous system on nerve
and muscle metabolism (1-3) led to an immunochemical study of muscle proteins
which indicated a change in protein structure (4-6) during denervation atrophy. It
is not known whether this response of protein configuration to denervation was in
the primary structure, similar to the case of the change from fetal to adult hemo-
globin, or whether the conformation (secondary structure) of the protein was
altered. The use of antibodies to enzymes seemed an excellent method with which
to probe the conformational dynamics of enzyme structure as it might occur during
enzyme function. If a conformation change, dependent on enzyme function obtains,
it would be evidence against the strict isomorphism between structure and function
that is usually implicit in theories of enzyme action. Recent reviews (7) on enzymes
discuss the evidence for "enzyme dynamics" as a mechanism of enzyme action.
This paper will present evidence of the kinetics of enzyme-antibody combination,
in the presence of substrates and competitive inhibitors, from which it may be
inferred that a configurational change takes place during enzyme-substrate combina-
tion.
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METHODS
Inasmuch as this paper is not intended to give in full the details of the immunoenzymology
of these enzymes but rather to concentrate on the evidence directly related to the experi-
ments suggesting a change in conformation, the methods will be outlined briefly.
Rabbit antisera were produced against chicken muscle 5'-adenylic acid deaminase
(deaminase) as described previously (8). Chicken antiserum to crystalline rabbit muscle
creatine-ATP-transphosphorylase1 (creatine kinase) was produced by repeated intra-
venous injection of large amounts (100 mg) of the enzyme. Blood was obtained by
cardiac puncture; the serum was separated and tested for precipitin and antienzyme
activity. In some cases the globulin fraction separated by 25 per cent ethanol was used.
Both deaminase and creatine kinase are completely inhibited upon combination with
their respective antibodies (8, 9). The rates of combination in the dilute enzyme-
antibody mixtures were followed by pipetting aliquots of the incubating mixture into
excess substrate at varying times. This determined the amount of free enzyme. Dilution
of the enzyme and antibody by a factor of 10 served to slow greatly the rate of combina-
tion. In addition, as will be shown in the results, substrate blocks further combination
of the enzyme and antibody.
Deaminase and its antibody were usually incubated at 37 degrees in 0.5 M KC1 con-
taining 0.1 M succinate at pH 6.0 and pipetted into 0.0043 M (AMP) 5' adenylic acid
in the same buffer. However, other pH's and ionic strengths were used to incubate the
enzyme and antibody. Conditions for creatine kinase were: 30°C, glycine buffer 0.1 M,
pH 9, 0.024 M creatine, 0.004 M MgSO4, 0.004 M ATP.
The activity of the enzymes was stopped with cold trichloracetic acid (7 ML of 5 per
cent for deaminase and 3 ML of 20 per cent for creatine kinase) and the supernatants
analyzed for the products, ammonia by direct nesslerization and phosphate by the Fiske-
SubbaRow method (10).
RESULTS
Fig. 1 shows the time course of inhibition. Curves B and E respectively in the
figure and its insert are of creatine kinase and deaminase inhibition. The activity for
the large figure is expressed in terms of micromoles of creatine phosphate formed
and in terms of NH3 for the insert. Curve A depicts incubation in control serum
showing little destruction of activity. Curve C is a plot of 1/activity versus time. In
this case the activity is converted into moles/liter of free enzyme2 and the inverse
plotted against time. Straight lines were found with both enzymes when the concen-
trations of the enzyme and antibody were very carefully adjusted to certain levels.
Theoretically this may be treated as a second order reaction in which the rate
constant of dissociation of the complex is disregarded, as it is assumed to be very
1 The author is greatly indebted to Dr. Lafayette Noda for suggestions that aided in crystalliz-
ing the enzyme in the initial attempt and for gifts of additional enzyme preparations.
2 Thus if at time T an aliquot was pipetted into the substrate and found to have a - x units
(15) of activity per ml, the moles of free enzyme is calculated by multiplying the dilution
factor by (a - x units/aO units) by the moles of crystalline enzyme added originally. This as-
sumes that only free enzyme has activity.
BIoPHYIsIcAL JOURNAL VOLUME 1 1961438
c Tm m! v mm A
2
20 \
0.16 '^
E
10 20
m i n ut e s
0 1 2 3 4 5 6
FIGuRE 1 Kinetics of inhibition and rate constant of enzyme-antibody formation.
Aliquots of the dilute mixture of enzyme and antibody are pipetted at indicated times
into substrate.
Main figure-0.004 M ATP, 0.004 M MgSO4, 0.024 M creatine, 0.1 M glycine pH
9.0, 300C.
Insert figure 0.0043 M AMP, 0.1 M succinate in 0.5 M KCI, pH 6.0, 37°C. Pro-
tection by AMP, 0.004 M added simultaneously to enzyme-antibody mixture.
much smaller than the rate constant of association. Even at low enzyme concentra-
tions the contribution of the dissociation term seems negligible (11). At equal con-
centrations of enzyme and antibody, the equation of this formally irreversible reac-
tion will integrate to
1 1 + kT
and a plot of 1/E versus T gives a straight line, the slope of which yields the appar-
ent rate constant of combination of the enzyme with the antibody. This is equal to
106 to 107 liter/mole/min. for creatine kinase. Chicken muscle deaminase and its
rabbit antibody give a rate constant of the same order of magnitude if one assumes
it has the same molecular weight as the rabbit muscle enzyme, i.e., 3.2 x 105 (12).
This assumption may be justified as it has a closely similar Km, 1.43 x 10-3 M
(5, 12), and the tumover number of purified, but not crystalline, preparations is
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3 x 106 moles/mole/hr. These rate constants are in agreement with the results of
Berson and Yalow (13) who have given 105 to 107 liter/mole/min. as the forward
rate constant and 109 to 1010 liter/mole as the equilibrium constant for the insulin-
antibody combination.
When substrate, AMP, is added to deaminase, simultaneously or immediately
prior to the addition of antibody, combination is prevented until the substrate is
exhausted. This is shown in Fig. 1 (insert, curve D) showing that inhibition starts
slowly after substrate is utilized, as compared to the rapid inhibition in the absence
of substrate. This "protection" (14) has also been shown in the case of other
enzyme-antibody systems. However, once combined, antibody is not displaced by
substrate, to any significant extent, as indicated by the fact that the Km of the
partially inhibited enzyme equals that of the free enzyme (9).
Phosphate Effect on Deaminase-Antibody Combination. Phosphate is a
competitive inhibitor of both chicken and rabbit deaminase (5, 12) and therefore
"binds" at the same site as substrate. It should block combination with antibody in
the same way as does AMP. However, it apparently increases the forward rate
constant and also increases the absolute amount of inhibition, at equilibrium, that
will be obtained with a given amount of antibody (9 and unpublished observation).
Fig. 2 is a graph of the inverse of the deaminase activity versus time. The slope of
these lines is proportional to the apparent rate constant of combination of the
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FIGuRE 2 Effect of phosphate ion on the rate constant of deaminase-antibody combi-
nation. Conditions as described for the experiment shown in Fig. 1, insert, curve E.
See text.
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deaminase and its antibody, and inasmuch as the enzyme and antibody are equal
in each of these experiments, the slopes are a measure of the rate of combination as
well. Fig. 2, line A, shows the rate of enzyme inhibition by antideaminase in the
absence of phosphate. Lines B and C show the increased rate constant in the pres-
ence of 0.1 and 0.2 M phosphate. Line D shows that in the presence of 0.2 M phos-
phate and control serum, under exactly the same conditions as in experiments B
and C, the deaminase is not inhibited. The lack of inhibition by phosphate is not
surprising because the concentration of phosphate is only 0.02 M after pipetting
the enzyme-serum-PO4 mixture into the substrate. This concentration of phosphate
does not inhibit the enzyme in the presence of these substrate concentrations. Yet, as
seen, with exactly the same concentration and under the same conditions, it does
potentiate the enzyme inhibition by the antibody (curves B and C). Curve E shows
that the rate constant of deaminase-antibody combination in the presence of
1 X 10-3 M fluoride is not changed, in spite of the fact that the enzyme is 50 per cent
inhibited by this non-competitive inhibitor. One may suggest then that the competi-
tive inhibitor allows more complete binding by the antibodies.
Creatine Kinase Inhibition. Creatine kinase requires three substrates
(15), creatine hydrate, ATP, and Mg++ ion. It has been clearly shown by both
groups (16, 17) working with creatine kinase that each of the substrates is bound
to the enzyme. Equilibrium dialysis experiments showed that 2 moles of each of the
substrates was bound per mole of protein with the exception of Mg++ of which 4
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FIGURE 3 Substrate protection against antibody inhibition of creatine kinase is af-
forded only when all substrates are added before the addition of antibody. Substrate
concentrations are similar to those of Fig. 1, main figure. The rate of creatine phos-
phate production (P) is a direct measure of the free enzyme concentration.
ARTHUR J. SAMUELS Immunoenzymological Evidence 441
were bound. The creatine and creatine phosphate binding were independent of Mg
concentration but the ATP and ADP binding was a function of the Mg++ concen-
tration which indicated that some complex was formed between these two substrates
in binding to the protein (17).
However, creatine kinase is not protected against combination with its antibody
by the simultaneous or prior addition of any one or a combination of two of the
substrates. Addition of the three substrates prior to the antibody does confer pro-
tection. This is illustrated in Fig. 3 which shows that creatine kinase incubated with
two substrates (creatine + Mg++) is inhibited upon the addition of antibody 2.5
min. prior to the addition of ATP (lower curve), while it is not inhibited as fast
when the third substrate is added 2.5 min. prior to the antibody, i.e., when the
enzyme is already working. The same relations obtain when creatine is added last.
Obviously, as the affinity of the antibody is much higher than that of the sub-
strate, unbound molecules of enzymes will be combined quite rapidly if the antibody
concentration is too high.
DISCUSSION
The determination of the rate constant of combination of an enzyme and its anti-
body is based upon the assumption that the enzyme is completely and immediately
inhibited upon combination with its specific antibody, before secondary complexes
are formed. An equilibrium constant may also be determined by maintaining the
antibody concentration constant in each tube and adding decreasing amounts of
enzyme to it. The per cent inhibition of the added enzyme at equilibrium may then
be converted into moles of bound enzyme and a plot of the ratio of bound/free
enzyme versus moles of bound enzyme yields a straight line with a negative slope,
which is equivalent to the equilibrium constant. This graph gives values of the
order of 109 liter/mole for creatine kinase, but technical difficulties and occasional
tendencies of this enzyme to increase activity on dilution, make the determination
of an exact value difficult.
Very much in accord with the above findings on substrate protection of creatine
kinase is the fact that much greater protection against heat denaturation has been
observed with creatine kinase when all three substrates are present (15) than with
any one singly. Previous work (14) has indicated that substrate protects enzyme
against antibody combination, but at least one case, that of lactic acid dehydrogenase
from rabbit muscle, has been shown to be an exception (18), for neither the
oxidized nor reduced form of the two substrates added singly prevented combina-
tion. No kinetic studies of enzyme-antibody combination in the presence of both
substrates were carried out in that work.
At first impression these results might be interpreted in terms of steric hindrance,
for the binding of the antibody anywhere in the vicinity of the substrate site would
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effectively block the approach of the substrate. Prior binding of the substrate could
effectively prevent the binding of the antibody by a similar mechanism. However,
the present results do not seem to fit this interpretation easily, for phosphate does
not prevent binding of the deaminase antibody, although its kinetics as a competitive
inhibitor indicate that it is bound at the same site on the enzyme as AMP which
does protect against antibody inhibition. On the contrary, it seems to enhance the
binding of more enzyme molecules by the antideaminase. However, its smaller size
and charge-altering properties perhaps induce better fit with the antibodies after it
is bound, rather than blocking as does the larger substrate. Furthermore, the mecha-
nism of simple steric hindrance does not seem adequate in the creatine kinase-anti-
body system, for antibody combination is not sterically hindered by prior binding
of two of the three components that form the substrate for this enzyme. The enzyme
is protected from antibody combination when it is working. Because of the size
of the antibody molecule, it seems unlikely that if it slips into position after the
Mg-ATP is bound, it could also bind in the same position after the Mg and creatine
are bound, for by the nature of the transfer reaction these substrates should be
bound to the protein rather close to each other. If the idea of simple steric hindrance
is to apply in this case, one might have to assume that the binding of the substrates
experienced during equilibrium dialysis (16, 17) studies has no geometric relation
to the binding that obtains during activation.
One interpretation of these results, especially those with creatine kinase, suggests
that the configuration of a large enough part of the enzyme is altered during activa-
tion by substrates so that combination with antibody is no longer able to occur.
Previous work has suggested that the antigen is deformed during combination with
antibody (19). Recent work showing a change in optical rotation during the forma-
tion of "antigen-poor" complexes (20) supports this suggestion. Reviews of the
enzyme literature (7), especially Koshland (in addition to his voluminous later
work), Lumry, Linderstrom-Lang, and Schellman, and more recently, Blum (21)
and others, also suggest, on the basis of kinetic and thermodynamic arguments, a
lability of enzyme structure or at least the active site. Changes in the optical rotation
of ribonuclease in the presence of pyrophosphate (22), and in glyceraldehyde-3-
phosphate dehydrogenase upon DPN binding (23, 24) as well as immunochemical
studies on urea-treated penicillinase (25) also indicate a conformation change
during substrate binding.
The optical rotation and rotatory dispersion of creatine kinase are being studied
here, and evidence recently reported (26) shows a small change in optical rotation
of the enzyme only when the enzyme is working. This strongly supports the most
probable interpretation of the immunoenzymological results reported here, that of a
conformation change. However, even this evidence is not irrefutable, as the forma-
tion of a new assymetric center, upon the binding of small molecules to proteins, is
possible (27).
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If a functionally related conformation change does indeed occur, it might be
viewed as an "induced fit" (see Koshland in reference 7), which as a mechanism
for general enhancement of specificity must be evaluated, or at the other extreme,
as a physiologic process, like a stimulus response, in which information is trans-
mitted to the protein causing a specific conformational change. If individual con-
formation changes of proteins occur during embryogenesis, aging, denervation
atrophy, and during various disease states, we begin to see a role that the complex
structure of proteins may play that is suggestive of the biological sensitivity to envir-
onment seen in organisms at higher levels of organization.
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